Cargando…
Health resource utilization and cost before versus after initiation of second-generation long-acting injectable antipsychotics among adults with schizophrenia in Alberta, Canada: a retrospective, observational single-arm study
BACKGROUND: Long-acting injectable (LAI) antipsychotics, along with community treatment orders (CTOs), are used to improve treatment effectiveness through adherence among individuals with schizophrenia. Understanding real-world medication adherence, and healthcare resource utilization (HRU) and cost...
Autores principales: | Wong, Kai On, Klarenbach, Scott W., Martins, Karen J. B., Chue, Pierre, Dursun, Serdar M., Snaterse, Mark, Guigue, Alexis, So, Helen, Luu, Huong, Vu, Khanh, Richer, Lawrence |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250716/ https://www.ncbi.nlm.nih.gov/pubmed/35780116 http://dx.doi.org/10.1186/s12888-022-04075-y |
Ejemplares similares
-
Health resource utilization, costs, and community treatment order status before and after the initiation of second-generation long acting-injectable antipsychotics in patients with schizophrenia in Alberta, Canada
por: Chue, P., et al.
Publicado: (2022) -
Incidence and prevalence, and medication use among adults living with dermatomyositis: an Alberta, Canada population-based cohort study
por: Osman, Mohammed, et al.
Publicado: (2023) -
Analgesic Use Among Adults with a Trauma-Related Emergency Department Visit: A Retrospective Cohort Study from Alberta, Canada
por: Sevcik, Bill, et al.
Publicado: (2023) -
Opioid use in medical cannabis authorization adult patients from 2013 to 2018: Alberta, Canada
por: Lee, Cerina, et al.
Publicado: (2021) -
Economic impact of self-administered subcutaneous versus clinic-administered intravenous immunoglobulin G therapy in Alberta, Canada: a population-based cohort study
por: Ritchie, Bruce, et al.
Publicado: (2022)